Project Grant HT94252510112

Award Date 3/1/25
Completion Date 2/28/29
Dollars Obligated $1.5M
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Orange, CA 92868, USA
Similar Awards
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $356,000.00 to The Children's Hospital of Philadelphia (CHOP) to study the impact on ketosis phenotype. The performance period for this award is from Sep 1, 2024 to Aug 31, 2026. As a leading pediatric research institution, CHOP leverages its expertise in areas such as genetic disorders and neurological conditions to contribute to...
This $1,746,810.00 federal Project Grant award was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research conducted by The Children's Hospital of Philadelphia (CHOP) to develop combination therapy approaches for treating high-risk, MYCN-amplified neuroblastoma, a type of pediatric cancer. The research project will run from July 1, 2025 to June 30, 2028. As a leading pediatric healthcare...
This $152,761 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports a research study at The Children's Hospital of Philadelphia (CHOP) investigating the use of quantitative sodium magnetic resonance imaging (MRI) and chemical exchange saturation transfer (CEST) to analyze low-grade gliomas in children with neurofibromatosis type 1. The 2-year study, which commenced on September 15, 2023, aims to advance diagnostic...
The Department of the Army Medical Command awarded a $925,594 Project Grant to The Children's Hospital of Philadelphia through the Military Medical Research and Development program. The grant will fund research from September 2022 through September 2025 to develop a non-invasive backpack optical spectroscopy system for diagnosing intracranial hypertension. The Children's Hospital of Philadelphia Research Institute will utilize the funding to investigate medical solutions for diagnosing...
The Children's Hospital of Philadelphia (CHOP) was awarded a $801,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research targeting "MARROW NICHE DYSREGULATION DURING STEM CELL TRANSPLANT FOR BONE MARROW FAILURE ASSOCIATED WITH MONOSOMY 7 MYELODYSPLASTIC SYNDROMES." This multi-year research project, running from September 1, 2023 to August 31, 2026, aims to investigate medical solutions...
The Department of the Army Medical Command awarded a $574,104 Project Grant to The Children's Hospital of Philadelphia through the Military Medical Research and Development program. The grant will fund research from September 2022 through September 2025 to develop a non-invasive backpack optical spectroscopy system for diagnosing intracranial hypertension. The Children's Hospital of Philadelphia Research Institute will utilize the three year period of performance to investigate medical solutions...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,366,365.00 to The Children's Hospital of Philadelphia (CHOP) to conduct a research study titled "BRAIN CHARTS IN CHILDREN AND ADOLESCENTS WITH NEUROFIBROMATOSIS TYPE 1". The study aims to advance healthcare for children by improving the understanding of brain development in those with neurofibromatosis type 1, a genetic disorder that...
The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,984,636 Project Grant to The Children's Hospital of Philadelphia (CHOP) to conduct research on identifying and reversing functional cerebellar circuit dysfunctions in Friedreich's ataxia mice. The grant, awarded on September 1, 2024, will support this research project over a 4-year period until August 31, 2028. As a leading pediatric research institution, CHOP will leverage...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,273,300 Project Grant to The Children's Hospital of Philadelphia (CHOP) to conduct research on identifying and reversing functional cerebellar circuit dysfunctions in a mouse model of Friedreich's ataxia. The grant, with a performance period from September 1, 2024 to August 31, 2028, will support CHOP's pioneering research efforts to advance understanding and treatment of this...
The Children's Hospital of Philadelphia (CHOP) has been awarded a $1,773,720.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. This award, with a period of performance from July 1, 2024 to June 30, 2028, will support research to elucidate the cardiomyopathy associated with the mitochondrial disorder Friedreich's ataxia. CHOP, a leading pediatric hospital and research facility, will leverage its expertise in areas like genetic...

This federal Project Grant award from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), provides $1,474,039.00 to the Children's Hospital of Orange County (CHOC) to conduct pharmacological research to prevent pediatric hydrocephalus. The award period runs from March 1, 2025 to February 28, 2029. As a prominent pediatric healthcare institution and non-profit organization, CHOC specializes in advanced medical research and clinical services. The organization has demonstrated extensive experience in federal grant-funded projects across various domains, including pediatric oncology, epilepsy, metabolic disorders, and mental health services. This specific grant will support CHOC's efforts to develop innovative pharmacological treatments to address the critical medical challenge of pediatric hydrocephalus.

Generated 6/10/25, 6:26 AM